Tag Archives: pharmaceutical equivalence isn’t therapeutic equivalence/FDA approval false advertising

pharmaceutical equivalence isn’t therapeutic equivalence/FDA approval

Concordia Pharmaceuticals Inc., S.À.R.L. v. Winder Laboratories, LLC, 2021 WL 3573118, No. 16-cv-00004-RWS (N.D. Ga. Feb. 17, 2021) Concordia makes DONNATAL, a combination of phenobarbital and belladonna alkaloids (PBA) used to treat irritable bowel syndrome (IBS) and acute enterocolitis. Winder … Continue reading

Posted in Uncategorized | Tagged , | Leave a comment